Turning Gray: The Natural History of Lung Cancer Over Time

As newer therapies for lung cancer are being explored it becomes more important to understand the natural history of lung cancer. A systematic review of the data shows that untreated lung cancer is almost uniformly rapidly fatal, even if it is stage I. Analysis of data regarding tumor volume doublin...

Full description

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2008-07, Vol.3 (7), p.781-792
Main Authors: Detterbeck, Frank C., Gibson, Christopher J.
Format: Article
Language:English
Subjects:
Animals
Doubling time
Humans
Lung cancer
Lung Neoplasms - diagnosis
Lung Neoplasms - mortality
Lung Neoplasms - pathology
Natural history
Prognosis
Screening
Survival Rate
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5175-6b168b78619ea836305e36d72855aa9329a92c568145319ec1eeb42659a11b73
cites cdi_FETCH-LOGICAL-c5175-6b168b78619ea836305e36d72855aa9329a92c568145319ec1eeb42659a11b73
container_end_page 792
container_issue 7
container_start_page 781
container_title Journal of thoracic oncology
container_volume 3
creator Detterbeck, Frank C.
Gibson, Christopher J.
description As newer therapies for lung cancer are being explored it becomes more important to understand the natural history of lung cancer. A systematic review of the data shows that untreated lung cancer is almost uniformly rapidly fatal, even if it is stage I. Analysis of data regarding tumor volume doubling times shows that conventionally detected lung cancers have short mean doubling times, and only a small proportion with very long doubling times. Lung cancers found during the course of a CT screening program have markedly longer mean doubling times and a substantially greater proportion with very long doubling times (>400 days). Models of tumor growth, however, are not understood well enough to use the observed doubling time to predict length of survival without treatment.
doi_str_mv 10.1097/JTO.0b013e31817c9230
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69279053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1556086415333530</els_id><sourcerecordid>69279053</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5175-6b168b78619ea836305e36d72855aa9329a92c568145319ec1eeb42659a11b73</originalsourceid><addsrcrecordid>eNp9kE1PGzEQhi1EBZT2H6BqT9yWzvhrbQ5IKGqhVdRc9m55nQkxbLLU3gXl39dVIiFx4DAeH97n1ehh7ALhCsE233-3iyvoAAUJNNgEywUcsTNUStcoDBwf_mC0PGWfc34EkAqkOWGnaJSVguszdt1OaRu3D9Vd8rvrql1T9cePU_J9dR_zOKRdNayq-VQSM78NlKrFS3nauKEv7NPK95m-HvY5a3_-aGf39Xxx92t2O6-DwkbVukNtusZotOSN0AIUCb1suFHKeyu49ZYHpQ1KJUomIFEnuVbWI3aNOGeX-9rnNPydKI9uE3OgvvdbGqbstOWNBSVKUO6DIQ05J1q55xQ3Pu0cgvuvzBVl7r2ygn079E_dhpZv0MHRW-_r0I-U8lM_vVJya_L9uHaAXApjZc0BDDQAUJdBVbCbPUbFzUssRA6RisJlTBRGtxzix4f9Awa-iKc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69279053</pqid></control><display><type>article</type><title>Turning Gray: The Natural History of Lung Cancer Over Time</title><source>ScienceDirect Journals</source><creator>Detterbeck, Frank C. ; Gibson, Christopher J.</creator><creatorcontrib>Detterbeck, Frank C. ; Gibson, Christopher J.</creatorcontrib><description>As newer therapies for lung cancer are being explored it becomes more important to understand the natural history of lung cancer. A systematic review of the data shows that untreated lung cancer is almost uniformly rapidly fatal, even if it is stage I. Analysis of data regarding tumor volume doubling times shows that conventionally detected lung cancers have short mean doubling times, and only a small proportion with very long doubling times. Lung cancers found during the course of a CT screening program have markedly longer mean doubling times and a substantially greater proportion with very long doubling times (&gt;400 days). Models of tumor growth, however, are not understood well enough to use the observed doubling time to predict length of survival without treatment.</description><identifier>ISSN: 1556-0864</identifier><identifier>EISSN: 1556-1380</identifier><identifier>DOI: 10.1097/JTO.0b013e31817c9230</identifier><identifier>PMID: 18594326</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Doubling time ; Humans ; Lung cancer ; Lung Neoplasms - diagnosis ; Lung Neoplasms - mortality ; Lung Neoplasms - pathology ; Natural history ; Prognosis ; Screening ; Survival Rate</subject><ispartof>Journal of thoracic oncology, 2008-07, Vol.3 (7), p.781-792</ispartof><rights>2008 International Association for the Study of Lung Cancer</rights><rights>2008International Association for the Study of Lung Cancer</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5175-6b168b78619ea836305e36d72855aa9329a92c568145319ec1eeb42659a11b73</citedby><cites>FETCH-LOGICAL-c5175-6b168b78619ea836305e36d72855aa9329a92c568145319ec1eeb42659a11b73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1556086415333530$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,3536,27905,27906,45761</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18594326$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Detterbeck, Frank C.</creatorcontrib><creatorcontrib>Gibson, Christopher J.</creatorcontrib><title>Turning Gray: The Natural History of Lung Cancer Over Time</title><title>Journal of thoracic oncology</title><addtitle>J Thorac Oncol</addtitle><description>As newer therapies for lung cancer are being explored it becomes more important to understand the natural history of lung cancer. A systematic review of the data shows that untreated lung cancer is almost uniformly rapidly fatal, even if it is stage I. Analysis of data regarding tumor volume doubling times shows that conventionally detected lung cancers have short mean doubling times, and only a small proportion with very long doubling times. Lung cancers found during the course of a CT screening program have markedly longer mean doubling times and a substantially greater proportion with very long doubling times (&gt;400 days). Models of tumor growth, however, are not understood well enough to use the observed doubling time to predict length of survival without treatment.</description><subject>Animals</subject><subject>Doubling time</subject><subject>Humans</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - diagnosis</subject><subject>Lung Neoplasms - mortality</subject><subject>Lung Neoplasms - pathology</subject><subject>Natural history</subject><subject>Prognosis</subject><subject>Screening</subject><subject>Survival Rate</subject><issn>1556-0864</issn><issn>1556-1380</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9kE1PGzEQhi1EBZT2H6BqT9yWzvhrbQ5IKGqhVdRc9m55nQkxbLLU3gXl39dVIiFx4DAeH97n1ehh7ALhCsE233-3iyvoAAUJNNgEywUcsTNUStcoDBwf_mC0PGWfc34EkAqkOWGnaJSVguszdt1OaRu3D9Vd8rvrql1T9cePU_J9dR_zOKRdNayq-VQSM78NlKrFS3nauKEv7NPK95m-HvY5a3_-aGf39Xxx92t2O6-DwkbVukNtusZotOSN0AIUCb1suFHKeyu49ZYHpQ1KJUomIFEnuVbWI3aNOGeX-9rnNPydKI9uE3OgvvdbGqbstOWNBSVKUO6DIQ05J1q55xQ3Pu0cgvuvzBVl7r2ygn079E_dhpZv0MHRW-_r0I-U8lM_vVJya_L9uHaAXApjZc0BDDQAUJdBVbCbPUbFzUssRA6RisJlTBRGtxzix4f9Awa-iKc</recordid><startdate>200807</startdate><enddate>200807</enddate><creator>Detterbeck, Frank C.</creator><creator>Gibson, Christopher J.</creator><general>Elsevier Inc</general><general>International Association for the Study of Lung Cancer</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200807</creationdate><title>Turning Gray: The Natural History of Lung Cancer Over Time</title><author>Detterbeck, Frank C. ; Gibson, Christopher J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5175-6b168b78619ea836305e36d72855aa9329a92c568145319ec1eeb42659a11b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Doubling time</topic><topic>Humans</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - diagnosis</topic><topic>Lung Neoplasms - mortality</topic><topic>Lung Neoplasms - pathology</topic><topic>Natural history</topic><topic>Prognosis</topic><topic>Screening</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Detterbeck, Frank C.</creatorcontrib><creatorcontrib>Gibson, Christopher J.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of thoracic oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Detterbeck, Frank C.</au><au>Gibson, Christopher J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Turning Gray: The Natural History of Lung Cancer Over Time</atitle><jtitle>Journal of thoracic oncology</jtitle><addtitle>J Thorac Oncol</addtitle><date>2008-07</date><risdate>2008</risdate><volume>3</volume><issue>7</issue><spage>781</spage><epage>792</epage><pages>781-792</pages><issn>1556-0864</issn><eissn>1556-1380</eissn><abstract>As newer therapies for lung cancer are being explored it becomes more important to understand the natural history of lung cancer. A systematic review of the data shows that untreated lung cancer is almost uniformly rapidly fatal, even if it is stage I. Analysis of data regarding tumor volume doubling times shows that conventionally detected lung cancers have short mean doubling times, and only a small proportion with very long doubling times. Lung cancers found during the course of a CT screening program have markedly longer mean doubling times and a substantially greater proportion with very long doubling times (&gt;400 days). Models of tumor growth, however, are not understood well enough to use the observed doubling time to predict length of survival without treatment.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>18594326</pmid><doi>10.1097/JTO.0b013e31817c9230</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1556-0864
ispartof Journal of thoracic oncology, 2008-07, Vol.3 (7), p.781-792
issn 1556-0864
1556-1380
language eng
recordid cdi_proquest_miscellaneous_69279053
source ScienceDirect Journals
subjects Animals
Doubling time
Humans
Lung cancer
Lung Neoplasms - diagnosis
Lung Neoplasms - mortality
Lung Neoplasms - pathology
Natural history
Prognosis
Screening
Survival Rate
title Turning Gray: The Natural History of Lung Cancer Over Time
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T21%3A27%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Turning%20Gray:%20The%20Natural%20History%20of%20Lung%20Cancer%20Over%20Time&rft.jtitle=Journal%20of%20thoracic%20oncology&rft.au=Detterbeck,%20Frank%20C.&rft.date=2008-07&rft.volume=3&rft.issue=7&rft.spage=781&rft.epage=792&rft.pages=781-792&rft.issn=1556-0864&rft.eissn=1556-1380&rft_id=info:doi/10.1097/JTO.0b013e31817c9230&rft_dat=%3Cproquest_cross%3E69279053%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5175-6b168b78619ea836305e36d72855aa9329a92c568145319ec1eeb42659a11b73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69279053&rft_id=info:pmid/18594326&rfr_iscdi=true